The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A DNA-Based Nanocarrier for Efficient Gene Delivery and Combined Cancer Therapy
Abstract
The efficient delivery of a therapeutic gene into target tissues has remained a major obstacle in realizing a viable gene-based medicine. Herein, we introduce a facile and universal strategy to construct a DNA nanostructure-based codelivery system containing a linear tumor therapeutic gene (p53) and a chemotherapeutic drug (doxorubicin, DOX) for combined therapy of multidrug resistant tumor (MCF-7R). This novel codelivery system, which is structurally similar to a kite, is rationally designed to contain multiple functional groups for the targeted delivery and controlled release of the therapeutic cargoes. The self-assembled DNA nanokite achieves efficient gene delivery and exhibits effective inhibition of tumor growth in vitro and in vivo without apparent systemic toxicity. These structurally and chemically well-defined codelivery nanovectors provide a new platform for the development of gene therapeutics for not only cancer but also a wide range of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folding DNA to create nanoscale shapes and patterns
Rothemund, P. W. K. (2006) · Nature · doi:10.1038/nature04586 · Cited by 7,354
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Lee, H., Lytton-Jean, A. K. R., Chen, Y., Love, K. T., Park, A. I., Karagiannis, E. D., Sehgal, A., Querbes, W., Zurenko, C. S., Jayaraman, M., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.73 · Cited by 1,169
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Wu, Q., Yang, Z., Nie, Y., Shi, Y., & Fan, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.013 · Cited by 776
Rare-disease genetics in the era of next-generation sequencing: discovery to translation
Boycott, K. M., Vanstone, M. R., Bulman, D. E., & MacKenzie, A. E. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3555 · Cited by 763
Engineering adeno-associated viruses for clinical gene therapy
Kotterman, M. A., & Schaffer, D. V. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3742 · Cited by 761
DNA Origami as a Carrier for Circumvention of Drug Resistance
Jiang, Q., Song, C., Nangreave, J., Liu, X., Lin, L., Qiu, D., Wang, Z.-G., Zou, G., Liang, X., Yan, H., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304263n · Cited by 736
Self-citationZanta, M. A., Belguise-Valladier, P., & Behr, J.-P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.91 · Cited by 722
Aptamers from Cell-Based Selection for Bioanalytical Applications
Tan, W., Donovan, M. J., & Jiang, J. (2013) · Chemical Reviews · doi:10.1021/cr300468w · Cited by 649
DNA Origami as an In Vivo Drug Delivery Vehicle for Cancer Therapy
Zhang, Q., Jiang, Q., Li, N., Dai, L., Liu, Q., Song, L., Wang, J., Li, Y., Tian, J., Ding, B., et al. (2014) · ACS Nano · doi:10.1021/nn502058j · Cited by 643
Self-citationImmune responses to gene therapy vectors: influence on vector function and effector mechanisms
Bessis, N., GarciaCozar, F. J., & Boissier, M.-C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302364 · Cited by 633
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
Inorganic Nanoparticles as Carriers of Nucleic Acids into Cells
Sokolova, V., & Epple, M. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703039 · Cited by 581
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
DNA Origami Delivery System for Cancer Therapy with Tunable Release Properties
Zhao, Y.-X., Shaw, A., Zeng, X., Benson, E., Nyström, A. M., & Högberg, B. (2012) · ACS Nano · doi:10.1021/nn3022662 · Cited by 519
Cellular Immunostimulation by CpG-Sequence-Coated DNA Origami Structures
Schüller, V. J., Heidegger, S., Sandholzer, N., Nickels, P. C., Suhartha, N. A., Endres, S., Bourquin, C., & Liedl, T. (2011) · ACS Nano · doi:10.1021/nn203161y · Cited by 495
Miyata, K., Nishiyama, N., & Kataoka, K. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15258k · Cited by 451
Smart Drug Delivery Nanocarriers with Self‐Assembled DNA Nanostructures
Li, J., Fan, C., Pei, H., Shi, J., & Huang, Q. (2013) · Advanced Materials · doi:10.1002/adma.201300875 · Cited by 441
Design of virus-based nanomaterials for medicine, biotechnology, and energy
Wen, A. M., & Steinmetz, N. F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00287g · Cited by 379
DNA Nanoflowers for Multiplexed Cellular Imaging and Traceable Targeted Drug Delivery
Hu, R., Zhang, X., Zhao, Z., Zhu, G., Chen, T., Fu, T., & Tan, W. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400323 · Cited by 337
Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy
Chang, M., Yang, C.-S., & Huang, D.-M. (2011) · ACS Nano · doi:10.1021/nn200693a · Cited by 318
Virus-Encapsulated DNA Origami Nanostructures for Cellular Delivery
Mikkilä, J., Eskelinen, A.-P., Niemelä, E. H., Linko, V., Frilander, M. J., Törmä, P., & Kostiainen, M. A. (2014) · Nano Letters · doi:10.1021/nl500677j · Cited by 308
Three-Dimensional Plasmonic Chiral Tetramers Assembled by DNA Origami
Shen, X., Asenjo-Garcia, A., Liu, Q., Jiang, Q., García de Abajo, F. J., Liu, N., & Ding, B. (2013) · Nano Letters · doi:10.1021/nl400538y · Cited by 293
Self-citationp53 as a target for the treatment of cancer
Duffy, M. J., Synnott, N. C., McGowan, P. M., Crown, J., O’Connor, D., & Gallagher, W. M. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.10.004 · Cited by 229
Halley, P. D., Lucas, C. R., McWilliams, E. M., Webber, M. J., Patton, R. A., Kural, C., Lucas, D. M., Byrd, J. C., & Castro, C. E. (2016) · Small · doi:10.1002/smll.201502118 · Cited by 227
Du, Y., Jiang, Q., Beziere, N., Song, L., Zhang, Q., Peng, D., Chi, C., Yang, X., Guo, H., Diot, G., et al. (2016) · Advanced Materials · doi:10.1002/adma.201601710 · Cited by 211
Self-citationKe, G., Liu, M., Jiang, S., Qi, X., Yang, Y. R., Wootten, S., Zhang, F., Zhu, Z., Liu, Y., Yang, C. J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201603183 · Cited by 156
Ouyang, X., Li, J., Liu, H., Zhao, B., Yan, J., Ma, Y., Xiao, S., Song, S., Huang, Q., Chao, J., et al. (2013) · Small · doi:10.1002/smll.201300458 · Cited by 148
Schaffert, D., Okholm, A. H., Sørensen, R. S., Nielsen, J. S., Tørring, T., Rosen, C. B., Kodal, A. L. B., Mortensen, M. R., Gothelf, K. V., & Kjems, J. (2016) · Small · doi:10.1002/smll.201503934 · Cited by 139
Synergistic gene and drug tumor therapy using a chimeric peptide
Han, K., Chen, S., Chen, W., Lei, Q., Liu, Y., Zhuo, R., & Zhang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.010 · Cited by 113
Attardi, L. D., de Vries, A., & Jacks, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207026 · Cited by 112
$1-million price tag set for Glybera gene therapy
Morrison, C. (2015) · Nature Biotechnology · doi:10.1038/nbt0315-217 · Cited by 107
Schakowski, F., Gorschlüter, M., Junghans, C., Schroff, M., Buttgereit, P., Ziske, C. G., Schöttker, B., König-Merediz, S. A., Sauerbruch, T., Wittig, B., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0322 · Cited by 98
Huang, J., Yang, J., Maity, B., Mayuzumi, D., & Fisher, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3397 · Cited by 87
Reyes‐Sandoval, A., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.008 · Cited by 87
Zhang, Y., Chao, J., Liu, H., Wang, F., Su, S., Liu, B., Zhang, L., Shi, J., Wang, L., Huang, W., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201512022 · Cited by 87
Opportunities and challenges in combination gene cancer therapy
Nastiuk, K. L., & Krolewski, J. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.005 · Cited by 85
Zhan, M., Yu, D., Lang, A., Li, L., & Pollock, R. E. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1556::aid-cncr1482>3.0.co;2-s · Cited by 68
Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity
Hofman, C., Dileo, J., Li, Z., Li, S., & Huang, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301373 · Cited by 65
Gene Therapy for “Bubble Boy” Disease
Hoggatt, J. (2016) · Cell · doi:10.1016/j.cell.2016.06.049 · Cited by 50
Monitoring intracellular degradation of exogenous DNA using diffusion properties
Sasaki, A., & Kinjo, M. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.013 · Cited by 48
Li, S.-Y., Brisson, M., He, Y., & Huang, L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300413 · Cited by 28
Wang, H., Chen, Z., Zhang, G., Ou, X., Yang, X., Wong, C. K. C., Giesy, J. P., Du, J., & Chen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047159 · Cited by 25
The utility of DNA nanostructures for drug delivery in vivo
Okholm, A. H., & Kjems, J. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1266335 · Cited by 22
Cited by
DNA Functional Materials Assembled from Branched DNA: Design, Synthesis, and Applications
Dong, Y., Yao, C., Zhu, Y., Yang, L., Luo, D., & Yang, D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00294 · Cited by 533
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Zhou, Y., Fan, S., Feng, L., Huang, X., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202104223 · Cited by 463
Supramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Self-citation
Metadata
- Authors
- Liu, J., Song, L., Liu, S., Jiang, Q., Liu, Q., Li, N., Wang, Z.-G., & Ding, B.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-04-30
- Volume
- 18
- Issue
- 6
- Pages
- 3328-3334
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2799602777
- Cited by
- 267
- References
- 49
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.